NCT02660645 2025-12-18
BLCCR
Photocure
Recruiting
Clinical Trials
14 trialsNCT06525571 2025-11-18
Outcomes of High-risk Non-muscle Invasive Bladder Cancer Treated With Blue Light Resection
Johns Hopkins University
Phase 3 Recruiting
NCT05600322 2024-10-03
Comparative Study of Hexvix Blue Light Cystoscopy and White Light Cystoscopy in the Detection of Bladder Cancer
Photocure
Phase 3 Completed
NCT06548438 2024-08-12
TUR_BLUE
A.O.U. Città della Salute e della Scienza
Phase 4 Not yet recruiting
NCT03058705 2019-08-19
Near Infrared Fluorescence Imaging for Bladder Cancer Detection
University of Rochester
Phase NA Completed
NCT02660190 2019-08-14
DaBlaCa-11
Aarhus University Hospital
Phase 3 Completed
NCT02560584 2018-07-02
A Study of Blue Light Flexible Cystoscopy With Cysview in the Detection of Bladder Cancer in the Surveillance Setting
Photocure
Phase 3 Completed
NCT01750970 2016-09-21
Endoscopic Resection of Bladder Tumors
Hopital Foch
Phase NA Completed
NCT00785694 2015-04-24
Recurrence of Bladder Cancer After Transurethral Resection With Hexvix
GE Healthcare
Phase 4 Withdrawn
NCT00634621 2014-08-25
Effectiveness of Hexaminolevulinate (Hexvix) in the Diagnosis and Treatment of Patients With Non-invasive Bladder Cancer
GE Healthcare
Completed
NCT00052637 2013-10-23
Cystoscopy and Hexyl 5-Aminolevulinate in Detecting Carcinoma In Situ in Patients With Bladder Cancer
Photocure
Phase 3 Completed
NCT00233402 2013-10-11
Study to Improve Detection and Early Recurrence Rate in Bladder Cancer Patients Using Hexvix Fluorescence Cystoscopy
Photocure
Phase 3 Completed
NCT00412971 2013-10-11
A Randomized, Comparative Study of Hexvix Fluorescence Cystoscopy and Standard Cystoscopy in Patients With Non-invasive Bladder Cancer
Photocure
Phase 3 Completed
NCT01551407 2012-10-25
Detection of Bladder Tumors After 30 Min Instillation of Hexvix
Photocure
Phase 2 Terminated